De-cancer / curatio / medicinae / renibus

Medicamenta Approbata pro Helium (renalis Cell) Libra

Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) pro renibus (renum cellula) cancer. Album quod includit nomina generica et torris nomen. Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. Medicinae non sit in renibus (renum cellula) cancer, quae non enumerantur hic.

Medicamenta Approbata pro Helium (renalis Cell) Libra

Afinitor (Everolimus)

Afinitor Disperz (Everolimus)

Aldesleukin

Avastin (Bevacizumab)

Avelumab

Axitinib

Bavencio (Avelumab)

Bevacizumab

Cabometyx (Cabozantinib-S-Insecta)

Cabozantinib-S-Insecta

Everolimus

II-II (Aldesleukin)

Inlyta (Axitinib)

Interleuquina-II (Aldesleukin)

Ipilimumab

Keytruda (Pembrolizumab)

Lenvatinib Mesylate

Lenvima (Lenvatinib Mesylate)

Mvasi (Bevacizumab)

Nexavar (Sorafenib Tosylate)

Nivolumab

Opdivo (Nivolumab)

Pazopanib Hydrochloride

Pembrolizumab

Proleukin (Aldesleukin)

Sorafenib Tosylate

Triticum Sunitinib

Sutent (Panicum Sunitinib)

Temsirolimus

Torisel (Temsirolimus)

Votrient (Pazopanib Hydrochloride)

Yervoy (Ipilimumab)